Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

about

Cancer nanobiotechnolgy.

P2860

Q54939079-2F15B8CD-BF8C-431E-991D-C0080380EC4F

P2860

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

Item

http://www.wikidata.org/entity/Q40248942

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

@en

type

Item

label

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

@en

prefLabel

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

@en

P1476

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine

@en

P2093

Peng Wang

http://www.w3.org/2001/XMLSchema#string

Peng Zhao

http://www.w3.org/2001/XMLSchema#string

Shuyun Dong

http://www.w3.org/2001/XMLSchema#string

Tiefeng Xu

http://www.w3.org/2001/XMLSchema#string

P2860

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma

A simple method for displaying the hydropathic character of a protein

Peptide Vaccine: Progress and Challenges

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Taking dendritic cells into medicine

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)

Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine

Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines.

Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

P2888

aps.2017.31

P304

914-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2017.31

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mingnan Chen

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28414197

http://www.w3.org/2001/XMLSchema#string

P932

5520189

http://www.w3.org/2001/XMLSchema#string

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

about

P2860

P2860

Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932